20 Feb 2014
Biotech company defends safety of Parkinson's experiment
A New Zealand biotech company has stopped recruiting more patients for a world first experiment treating Parkinson's disease while the trial's safety is re-checked.
Show status: Off air
Recent stories from Checkpoint
Get the RNZ app
for easy access to all your favourite programmes
